|
|
||||||
 |
BioPortfolio Bulletin | |||||
| www.bioportfolio.com |
http://www.bioportfolio.co.uk/bulletin_42.htm June 8 2004 | |||||
|
| ||||||
|
||||||
|
|
||||||
|
In this Week's issue: 1) Dovebid - major sale of Genomic Research and Lab Equipment - see above 2) Dovebid - major sale of Lab Equipment Ultra-Modern Biopharmaceutical Research and Development Facility 3) BIOPHEX - 2004 Conference - Sept 28th to 30th - from post discovery to market 4) Biotechnology Management Practices - get your management right to prosper! 5) Reuters Business Insight - Buy one get one free special offer - Pharmaceutical Portfolio Management 6) BioAnnouncement - 50,000 emails to prospective customers in the life science space
|
||||||
|
|
||||||
| VIROPHARMA Webcast Auction 9th June | ||||||
|
|
VIROPHARMA AUCTION Private Treaty Sale Followed By a 1-Day Webcast Auction of Lab Equipment at a 100,000 Square Foot Ultra-Modern Biopharmaceutical Research and Development Facility.
Webcast Auction Wednesday, June 9, 2004 Beginning at 9:00 AM (ET). Bid Live in Exton, PA or on DoveBid's
website: www.dovebid.com. For more information, visit our website or call 800-665-1042. http://www.dovebid.com/Auctions/AuctionDetail.asp?auctionID=2554&referraltag=viro1b
|
|||||
| BIOPHEX 2004 Conference - from post-discovery to market | ||||||
|
BIOPHEX delivers a unique perspective on
the strategic and managerial issues that affect everyone in post-discovery
development and manufacturing. The conference, produced by Genetic
Engineering News, is targeted to help top-level biopharmaceutical
professionals successfully transition their drug from post-discovery to
market. For more information open:
|
|||||
| Biotechnology Management Practices | ||||||
|
Mardis Aibel have performed a unique study:
Most business executives would argue that companies lacking basic management skills are unlikely to succeed in the marketplace or generate significant returns for shareholders. Nevertheless, both managers and investors in numerous biotechnology firms seem to believe that this standard wisdom does not hold true for them. Research completed last year by Mardis, Aibel & Associates shows that a substantial portion of biotech executives view “achieving operational excellence” as a secondary concern. Many report that a significantly higher priority is “validating the scientific concept”, “searching for funding” or “publicizing the work of the firm”. Similarly, many biotech investors quietly acknowledge that they care less about creating firms with viable management models than in pushing firms to the next news announcement that will drive a jump in valuation. The all-too-common belief for many in the industry is that, for biotech's, first-class management is not needed to achieve world-class returns. They are wrong. For more information open:
|
|||||
| Reuters Business Insight OFFER - Buy one get one free special offer | ||||||
|
|
Pharmaceutical Portfolio Management: Integrated decision-making in marketing and R&D, is a strategic management report that presents a comprehensive overview of effective portfolio management processes, with a focus on better preparing senior management, R&D and marketing executives for integrated decision-making across the organization as a whole. Use this report to improve product lifecycle decisions and ensure the right people are involved in making the right decisions, at the right time. June Promotion – SAVE £745/€1199/$1199 Purchase the ‘Pharmaceutical Portfolio Management’ report before Friday 11th June 2004, and receive a FREE report of your choice from the list below: Choose your free report from the list below:
Reuters Business
Insight reports are published by Datamonitor, in association with Reuters.
Reuters, the sphere logo and Reuters Business Insight are trade marks of
the Reuters group of companies around the world and are used by
Datamonitor under licence from Reuters. To order email peter.barfoot@bioportfolio.com or purchase online at: http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_2003.html#a153
|
|||||
| BioAnnouncements - promoting technology to the life science sector | ||||||
|
Do you have technology that you wish to license?
Do you want to contact 50,000 life science users? Complete the online enquiry form - click here!
|
In 2004, LeadDiscovery & BioPortfolio, two of the largest drug development information providers combined their resources to launch BioAnnouncements. Through this service, LeadDiscovery distributes dedicated mail shots announcing licensing opportunities and R&D services to the drug discovery community. Interested? Email: leaddiscovery@leaddiscovery.co.uk Read more: http://www.leaddiscovery.co.uk/adpage.html
|
|||||
|
Contact
us:
To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com
WITH NO SUBJECT. The system will automatically remove
your email address from the list based on your email
address. If your email has changed please email peter.barfoot@bioportfolio.com
with a list of your email address and we will manually
unsubscribe for you. Thank you for your understanding.
©2004 BioPortfolio Limited | ||||||
|
| ||||||
